Correlation among CD24-, CD44-, and SSEA4-expressing subpopulations. To address the correlation between CD24, CD44, and SSEA4 expression, we performed costaining of these markers on residual tumor nodules after AC chemotherapy and untreated tumors of three independent models: HBCx-6 (a), HBCx-10 (b), and HBCx-14 (c). Regulation of the three markers did not correlate among the treatment cycles. (PNG 1664 kb
Figure S3. (A) TU-BCx-2 K1 explants were embedded in 40% Matrigel and immunofluorescence was employe...
Validation of miRNA candidates using a flow cytometry–based 39-plex miRNA assay. (a) Cluster analysi...
Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...
Tumor-initiating capacity of the SSEA4-positive and SSEA4-negative subpopulation. (a) One hundred th...
Expression of SSEA4 in RCC and healthy kidney tissue. Primary RCC and healthy kidney tissues from th...
Treatment history of breast cancer patients. Detailed description of treatment history of breast can...
Supplemental experimental procedures. Detailed description of materials and methods. (DOCX 62 kb
SSEA4-positive breast cancer cells show decreased expression of miRNAs inhibiting EMT inducers. Expr...
Results of microarray analysis. Results of gene and miRNA expression profiling, Gene Ontology analys...
Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb
Supplementary Figure S1-S17 show the methods of CTC analysis and CTC-associated survival (S1); glyco...
Treatment with diverse anticancer agents increases CD26 while also enhancing CD44+, but lowering CD1...
INTRODUCTION: Chemotherapy resistance resulting in incomplete pathologic response is associated wit...
Figure S1. Expression of CD24 luminal marker in MPS derived from variant vMCF-7∆Raf1 and vMCF-7∆Raf1...
Representative gating strategy for flow cytometry–based marker analysis of dissociated xenograft tum...
Figure S3. (A) TU-BCx-2 K1 explants were embedded in 40% Matrigel and immunofluorescence was employe...
Validation of miRNA candidates using a flow cytometry–based 39-plex miRNA assay. (a) Cluster analysi...
Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...
Tumor-initiating capacity of the SSEA4-positive and SSEA4-negative subpopulation. (a) One hundred th...
Expression of SSEA4 in RCC and healthy kidney tissue. Primary RCC and healthy kidney tissues from th...
Treatment history of breast cancer patients. Detailed description of treatment history of breast can...
Supplemental experimental procedures. Detailed description of materials and methods. (DOCX 62 kb
SSEA4-positive breast cancer cells show decreased expression of miRNAs inhibiting EMT inducers. Expr...
Results of microarray analysis. Results of gene and miRNA expression profiling, Gene Ontology analys...
Antibodies used for the screening approach. Detailed description of used antibodies. (DOCX 46 kb
Supplementary Figure S1-S17 show the methods of CTC analysis and CTC-associated survival (S1); glyco...
Treatment with diverse anticancer agents increases CD26 while also enhancing CD44+, but lowering CD1...
INTRODUCTION: Chemotherapy resistance resulting in incomplete pathologic response is associated wit...
Figure S1. Expression of CD24 luminal marker in MPS derived from variant vMCF-7∆Raf1 and vMCF-7∆Raf1...
Representative gating strategy for flow cytometry–based marker analysis of dissociated xenograft tum...
Figure S3. (A) TU-BCx-2 K1 explants were embedded in 40% Matrigel and immunofluorescence was employe...
Validation of miRNA candidates using a flow cytometry–based 39-plex miRNA assay. (a) Cluster analysi...
Figure S1. Representative immunohistochemistry (IHC) staining images for CD8, CD4, CD20 and CD68. Im...